Stock Events

Stock Events

Karyopharm Therapeutics (KPTI) Q3 2025 Earnings

11AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-4.42

-3.03

-1.65

-0.26

Details

Expected EPS

-4.081667

Actual EPS

-4.32

Surprise EPS

-0.24

Surprise Percent

+5.84%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -4.32 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.